| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-07 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |